CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00
By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT 1st Quarter 2024 Financial Results CytoSorbents (NASDAQ:CTSO) reported 1st quarter 2024 results on May 9th and results were broadly in line with expectations. For the 1st quarter of 2024,...
Zacks Small Cap Research